Biotech Showcase™ 2016: Interview: Placental stem therapy offers "off the shelf" promise

February 23, 2016
Pluristem Therapeutics chairman and CEO Zami Aberman explains to Mike Ward, global director of content for Informa Pharma Insights how stem cell therapy will shape the industry. Using placental cells and a proprietary, three-dimensional (3D) technology platform, Pluristem is developing “off the shelf” cell therapies for a broad spectrum of diseases. Pluristem converts human placental stem cells into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. The company’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. Aberman tells Mike Ward that his company intends to use the USD 17 million it raised in 2015 to complete current clinical studies and start new ones. Find more videos and articles at http://www.partnering360.com/insight For more information on Biotech Showcase™, visit our webpage: http://www.ebdgroup.com/bts/index.php
Previous Video
Biotech Showcase™ 2016: Interview: Whole genome sequencing in 25 minutes with Edico Genome
Biotech Showcase™ 2016: Interview: Whole genome sequencing in 25 minutes with Edico Genome

Within 10 years, genomics is going to account for the biggest big data challenge. Dr. Pieter van Rooyen, pr...

Next Video
Biotech Showcase™ 2016: KPI Therapeutics chief explains company's virtual business model
Biotech Showcase™ 2016: KPI Therapeutics chief explains company's virtual business model

KPI Therapeutics president and CEO Dr. Charles Magness explains to Mike Ward, Informa Pharma Insights globa...